NEW YORK (GenomeWeb News) – Molecular diagnostic firm Linkage Biosciences today announced it raised $2 million in growth capital.
The company did not specify how the funds will be used, but CEO Zachary Antovich noted growing demand for the firm's LinkSeq products and said in a statement that the funds will "help accelerate our efforts around the world."
Fisher Capital led the round. All existing investors, including Greenhouse Capital Partners and Big Sky Partners, also participated, Linkage Bio said
The San Francisco-based company also announced new distribution partners. GenDx Products will distribute Linkage Bio's products in the Benelux region. It has also partnered with Inydia Diagnostica in Spain and Portugal, Commugen in South Korea, and Ortner Medical Supplies in Austria.
Financial and other terms of the distribution deals were not disclosed.
Linkage develops PCR-based molecular diagnostics targeting human leukocyte antigen typing.